Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Eric Klug"'
Autor:
Dineo Mpanya, Mike Sathekge, Eric Klug, Jenna Damelin, Stuart More, Bawinile Hadebe, Mariza Vorster, Nqoba Tsabedze
Publikováno v:
Frontiers in Nuclear Medicine, Vol 3 (2023)
Gallium-68 fibroblast activation protein inhibitor [(68Ga)Ga-FAPI] is a new radiopharmaceutical positioning itself as the preferred agent in patients with malignant tumours, competing with 2-Deoxy-2-[18F]fluoro-d-glucose [2-(18F)FDG] using positron e
Externí odkaz:
https://doaj.org/article/d0cde054c9664f109ec1232a26f0c930
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2023)
BackgroundThe age of onset and causes of heart failure differ between high-income and low-and-middle-income countries (LMIC). Heart failure patients in LMIC also experience a higher mortality rate. Innovative ways that can risk stratify heart failure
Externí odkaz:
https://doaj.org/article/76e3ff41232a4eda940e3cc400e38919
Autor:
Nqoba Tsabedze, Jamie-Leigh Hayes Kinsey, Dineo Mpanya, Vanessa Mogashoa, Eric Klug, Pravin Manga
Publikováno v:
International Journal of Mental Health Systems, Vol 15, Iss 1, Pp 1-6 (2021)
Abstract Background Mental health illnesses are associated with frequent hospitalisation and an increased risk of all-cause mortality. Despite the high prevalence of depression in patients with chronic heart failure (CHF), there is a paucity of data
Externí odkaz:
https://doaj.org/article/c85db2643491484d87d31589026c60c3
Publikováno v:
Applied Sciences, Vol 13, Iss 3, p 1509 (2023)
Background: The diagnosis and therapy of heart failure are guided mainly by a single imaging parameter, the left ventricular ejection fraction (LVEF). Recent studies have reported on the value of machine learning in characterising the various phenoty
Externí odkaz:
https://doaj.org/article/30fb1e7cf1d545b99bc336273164be44
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 34, Iss , Pp 100773- (2021)
Objective: The partnership between humans and machines can enhance clinical decisions accuracy, leading to improved patient outcomes. Despite this, the application of machine learning techniques in the healthcare sector, particularly in guiding heart
Externí odkaz:
https://doaj.org/article/b7db9514e6064023b8b14260bb1da8f8
Autor:
Eric Klug
Publikováno v:
SA Heart Journal, Vol 5, Iss 3, Pp 124-127 (2017)
The progress made in the medical and device therapy of chronic heart failure (CHF) due to left ventricular systolic dysfunction has heralded new problems. Patients present having survived longer with CHF, but with minimal exercise reserve and renal d
Externí odkaz:
https://doaj.org/article/29a27b437d3c4d43926330caa680b241
Publikováno v:
Heart Failure Reviews. 26:545-552
Heart failure is a debilitating clinical syndrome associated with increased morbidity, mortality, and frequent hospitalization, leading to increased healthcare budget utilization. Despite the exponential growth in the introduction of pharmacological
Autor:
Roopa Mehta, Otavio Berwanger, Anwar Santoso, Viacheslav Mareev, Mikhail Kosiborod, Subodh Verma, Kim A. Connelly, Eric Klug, Mustafa Arici, Gus Meglis, Zhanna Kobalava
Publikováno v:
Current Opinion in Cardiology. 35:589-601
Purpose of review The management of individuals who live with type 2 diabetes requires an integrated and multifaceted approach. Recent findings Sodium-glucose cotransporter 2 inhibitors effectively prevent and treat cardiorenal complications in the p
Autor:
Mark Abelson, Rudolf Du Toit, Farrel Hellig, Adie Horak, Jacques van Wyk, Thomas Mabin, Hellmuth Weich, Anton Doubell, Jacques Scherman, Mpiko Ntsekhe, Elizabeth Schaafsma, Eric Klug
Publikováno v:
SA Heart. 18
Background: One of the most common complications post transcatheter aortic valve implantation (TAVI) is the development of heart block requiring permanent pacemaker implantation (PPM). The incidence of PPM in international registries ranges from 13%
Publikováno v:
Cardiovascular Journal of Africa. 30:103-107
Background Despite the significant clinical benefits of beta-blockers in heart failure with reduced ejection fraction (HFrEF), prescription for and adherence to these agents is reported to be poor. There are few data on the use and tolerance of beta-